Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMBR | P28336 | 2/20 | 0.63 |
| ▸ | GRPR | P30550 | 2/20 | 0.63 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.60 |
| ▸ | GLP1R | P43220 | 6/20 | 0.58 |
| ▸ | CCKBR | P32239 | 2/20 | 0.58 |
| ▸ | F2 | P00734 | 4/20 | 0.58 |
| ▸ | CALCR | P30988 | 4/20 | 0.56 |
| ▸ | GCGR | P47871 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25460022 | 0.97 | NMBR (0.63) | NMBRGRPRC5AR1GLP1RCCKBR | |
| SCHEMBL30891928 | 0.97 | NMBR (0.63) | NMBRGRPRC5AR1GLP1RCCKBR | |
| SCHEMBL25845917 | 0.93 | NMBR (0.66) | NMBRGRPRC5AR1GLP1RCCKBR | |
| SCHEMBL25845909 | 0.93 | NMBR (0.66) | NMBRGRPRC5AR1GLP1RCCKBR | |
| SCHEMBL22807694 | 0.92 | NPY1R (0.62) | GLP1R | |
| SCHEMBL29496930 | 0.92 | NPY1R (0.62) | GLP1R | |
| SCHEMBL25460148 | 0.89 | NMBR (0.65) | NMBRGRPRC5AR1GLP1RCCKBR | |
| SCHEMBL22872738 | 0.89 | NPY1R (0.61) | NMBRGRPRGLP1R | |
| SCHEMBL29450228 | 0.88 | F2 (0.60) | NMBRGRPRC5AR1GLP1RCCKBR | |
| SCHEMBL14930600 | 0.88 | NMBR (0.58) | NMBRGRPRGLP1RCCKBRF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118510547-A | Targeted linear conjugates comprising polyethylenimine and polyethylene glycol and polymer complexes comprising the same | 塔尔格免疫治疗有限公司 | 2024-08-16 | — | — | CN | disclosed |